GlassScriptPhysician profile
Kristine R Lewis
NPI 1598746547
$4,401.77
in general payments reported to CMS, 2019-2025
38 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,900 · 2022: $816 · 2023: $633 · 2024: $555 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,666 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.61 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $541.28 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $411.11 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $409.16 | 2021-2025 | |
| Eisai INC. | $288.88 | 2021-2022 | |
| Lilly USA, LLC | $280.91 | 2021-2024 | Jardiance, Mounjaro, Emgality |
| Novo Nordisk INC | $268.79 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $262.41 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $249.50 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $208.15 | 2021-2023 | Trulance |
| Mylan Specialty L.P. | $165.96 | 2021-2024 | Yupelri |
| Ironwood Pharmaceuticals, INC | $152.27 | 2021-2025 | Linzess |
| Esperion Therapeutics, INC. | $103.77 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $94.21 | 2021-2023 | |
| Pfizer INC. | $93.30 | 2021-2022 | |
| Amarin Pharma, INC. | $75.52 | 2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristine Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.